EYPT compared with BNTC: revenue, margins and what each company keeps, and the suppliers and customers both name

EYPTEyePoint, Inc.

Mkt capRevenueRevenue

BNTCBenitec Biopharma Inc.

Mkt capRevenueRevenue

Compare

EYPTEyePoint, Inc.

BNTCBenitec Biopharma Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

EYPT: latest quarter is a loss; flow not drawable. BNTC: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

EYPT, solidBNTC, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only EYPT 7

ANIPANI Pharmaceuticalscustomer

—Aerpio Pharmaceuticals Inc. (Aerpio)unlistedsupplier

—Equinox Scienceunlistedsupplier

—Farmabiosunlistedsupplier

3 more · EYPT chain ›

Shared 0

No shared counterparties.

Only BNTC 2

—Australian governmentunlistedsupplier

—Axovant Therapeuticsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

EYPTEyePoint, Inc.

0.35▼−8.34%· post 0.34

Mkt cap$30.0MRevenue$507,000Q2 FY26Revenue$31MFY25

BNTCBenitec Biopharma Inc.

8.77▼−0.67%· post 8.77

ClosedOct 30 '26

Mkt cap$304.9MRevenue$7,000Q4 FY23Revenue—

Compare

ClosedOct 30 '26

EYPTEyePoint, Inc.

BNTCBenitec Biopharma Inc.

0.35▼−8.34%post 0.34

Price

8.77▼−0.67%post 8.77

$30.0M

Mkt cap

$304.9M

Q2 FY26$507,000

Revenue

$7,000Q4 FY23

FY25$31M

Revenue

—

EYPT0.35▼−8.34%vsBNTC8.77▼−0.67%ClosedOct 30 '26